Gofen & Glossberg’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $8.66M | Sell |
51,494
-4,724
| -8% | -$821K | 0.22% | 106 |
|
|
2022
Q3 | $9.96M | Buy |
56,218
+2,252
| +4% | +$445K | 0.28% | 84 |
|
|
2022
Q2 | $11M | Buy |
53,966
+2,360
| +5% | +$500K | 0.29% | 81 |
|
|
2022
Q1 | $12.3M | Buy |
51,606
+920
| +2% | +$216K | 0.28% | 83 |
|
|
2021
Q4 | $11.6M | Buy |
50,686
+2,128
| +4% | +$468K | 0.25% | 88 |
|
|
2021
Q3 | $9.39M | Buy |
48,558
+3,635
| +8% | +$736K | 0.22% | 100 |
|
|
2021
Q2 | $9.55M | Buy |
44,923
+1,255
| +3% | +$265K | 0.23% | 98 |
|
|
2021
Q1 | $8.92M | Buy |
43,668
+22,775
| +109% | +$4.49M | 0.23% | 96 |
|
|
2020
Q4 | $3.8M | Buy |
20,893
+5,911
| +39% | +$1.01M | 0.1% | 140 |
|
|
2020
Q3 | $2.51M | Buy |
14,982
+988
| +7% | +$166K | 0.08% | 147 |
|
|
2020
Q2 | $2.27M | Buy |
13,994
+820
| +6% | +$147K | 0.08% | 149 |
|
|
2020
Q1 | $2.28M | Buy |
13,174
+5,880
| +81% | +$1.17M | 0.09% | 143 |
|
|
2019
Q4 | $1.46M | Buy |
7,294
+2,647
| +57% | +$543K | 0.05% | 183 |
|
|
2019
Q3 | $982K | Buy |
4,647
+820
| +21% | +$171K | 0.03% | 214 |
|
|
2019
Q2 | $743K | Hold |
3,827
| – | – | 0.03% | 235 |
|
|
2019
Q1 | $630K | Buy |
3,827
+114
| +3% | +$20.2K | 0.02% | 244 |
|
|
2018
Q4 | $698K | Hold |
3,713
| – | – | 0.03% | 226 |
|
|
2018
Q3 | $632K | Hold |
3,713
| – | – | 0.02% | 253 |
|
|
2018
Q2 | $609K | Sell |
3,713
-100
| -3% | -$16.3K | 0.02% | 249 |
|
|
2018
Q1 | $617K | Hold |
3,813
| – | – | 0.02% | 252 |
|
|
2017
Q4 | $557K | Hold |
3,813
| – | – | 0.02% | 275 |
|
|
2017
Q3 | $517K | Sell |
3,813
-2,886
| -43% | -$365K | 0.02% | 284 |
|
|
2017
Q2 | $839K | Sell |
6,699
-250
| -4% | -$29.9K | 0.03% | 230 |
|
|
2017
Q1 | $826K | Sell |
6,949
-114
| -2% | -$13.7K | 0.03% | 228 |
|
|
2016
Q4 | $815K | Sell |
7,063
-250
| -3% | -$27.8K | 0.03% | 224 |
|
|
2016
Q3 | $764K | Sell |
7,313
-10
| -0.1% | -$1.04K | 0.03% | 232 |
|
|
2016
Q2 | $713K | Buy |
7,323
+26
| +0.4% | +$2.46K | 0.03% | 242 |
|
|
2016
Q1 | $701K | Sell |
7,297
-481
| -6% | -$43.8K | 0.03% | 238 |
|
|
2015
Q4 | $705K | Hold |
7,778
| – | – | 0.03% | 232 |
|
|
2015
Q3 | $721K | Buy |
7,778
+23
| +0.3% | +$2.19K | 0.03% | 232 |
|
|
2015
Q2 | $722K | Hold |
7,755
| – | – | 0.03% | 237 |
|
|
2015
Q1 | $734K | Sell |
7,755
-500
| -6% | -$46.3K | 0.03% | 240 |
|
|
2014
Q4 | $732K | Hold |
8,255
| – | – | 0.03% | 237 |
|
|
2014
Q3 | $660K | Sell |
8,255
-935
| -10% | -$70.5K | 0.03% | 237 |
|
|
2014
Q2 | $652K | Sell |
9,190
-435
| -5% | -$30.6K | 0.03% | 236 |
|
|
2014
Q1 | $711K | Buy |
9,625
+80
| +0.8% | +$6.04K | 0.03% | 224 |
|
|
2013
Q4 | $749K | Sell |
9,545
-875
| -8% | -$68.5K | 0.04% | 218 |
|
|
2013
Q3 | $770K | Hold |
10,420
| – | – | 0.04% | 209 |
|
|
2013
Q2 | $791K | Buy |
+10,420
| New | +$684K | 0.04% | 195 |
|
Other funds holding CME
Gofen & Glossberg's CME Position: Q4 2022 in Review
Gofen & Glossberg reduced its CME Group (CME) stake by 8.4% in Q4 2022, selling an estimated $821K and leaving 51,494 shares worth $8.66M. The position accounts for 0.22% of the portfolio, ranked #106.
Gofen & Glossberg first reported a position in CME in Q2 2013 and has held it in 39 quarters since. The position peaked at $12.3M in Q1 2022. 1,150 funds tracked by Wall St. Rank hold CME as of Q4 2022.
- Gofen & Glossberg held 51,494 shares of CME Group worth $8.66M as of Q4 2022.
- Gofen & Glossberg sold 4,724 CME Group shares in Q4 2022, an estimated $821K.
- CME Group made up 0.22% of Gofen & Glossberg's portfolio in Q4 2022, its #106 holding.
- Gofen & Glossberg first reported a position in CME Group in Q2 2013 and has held it in 39 quarters since.
- Gofen & Glossberg's CME Group position peaked at $12.3M in Q1 2022.
- 1,150 funds tracked by Wall St. Rank held CME Group as of Q4 2022.
Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.